This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brouland, J.-P. Articles by Drouet, L. Search for Related Content PubMed PubMed Citation Articles by Brouland, J.-P. Articles by Drouet, L. Related Collections Endothelium/vascular type/nitric oxide Animal models of human disease CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:3055.)
© 1999 American Heart Association, Inc.

Thrombosis

In Vivo Regulation of von Willebrand Factor Synthesis

von Willebrand Factor Production in Endothelial Cells After Lung Transplantation Between Normal Pigs and von Willebrand Factor–Deficient Pigs

Jean-Philippe Brouland; Thomas Egan; Jacqueline Roussi; Michel Bonneau; Georges Pignaud; Claire Bal; Marcel Vaiman; Patrick André; Philippe Hervé; Guy Michel Mazmanian; Ludovic Drouet

From the Institut des Vaisseaux et du Sang (J.-P.B., C.B., P.A., L.D.) and Service d’Anatomie et Cytologie Pathologiques (J.-P.B.), Hôpital Lariboisière, Paris, France; the University of North Carolina (T.E.), Chapel Hill; INSERM U 353 (J.R., G.P., P.A., L.D.), Hôpital Saint-Louis, Paris, France; Laboratoire d’Hématologie (J.R.), Hôpital Raymond Poincaré, Garches France; LEPSD-INRA (M.B.), Jouy en Josas, France; CEA-INRA (M.V.), Jouy en Josas, France; Laboratoire de Physiologie (P.H.) and Centre Médico-chirurgical Hôpital Marie Lannelongue (G.M.M.), Le Plessis Robinson, France; and Angio-hématologie (L.D.), Hôpital Lariboisière, Paris, France.

Correspondence to Dr Jean-Philippe Brouland, Service d’Anatomie et Cytologie Pathologiques, Hôpital Lariboisière, 75475 Paris Cédex 10, France. E-mail jean-philippe.brouland{at}lrb.ap-hop-paris.fr

Abstract—To evaluate the regulation of plasma von Willebrand factor (vWF) and its in situ production by endothelial cells (ECs), 12 swine leukocyte antigen (SLA)-compatible left lung transplantations were performed. Normal lungs were transplanted into 10 pigs homozygous for von Willebrand disease and into 2 normal pigs. Additionally, 1 normal pig underwent pneumonectomy, and 1 SLA-incompatible lung transplantation between normal pigs was performed. None of the transplanted animals received immunosuppressive therapy. Plasma vWF level was evaluated by ELISA and multimeric pattern. EC vWF content was assessed by immunohistochemistry. Global hemostasis was assessed by standardized ear bleeding time. Six of 12 SLA-compatible lung transplantations and the incompatible transplantation were successful and were used for the study. The functions and the viability of ECs, reflected by their ability to produce vWF and normal multimeric plasma vWF pattern, were preserved in SLA-compatible and -incompatible lung transplantations. vWF production was preserved in ECs that initially synthesized it. EC constitutive and storage pathways are modulated differently according to transplantation compatibility and severity of rejection. In SLA-compatible lung transplantations without histological evidence of rejection, the production of vWF was preserved, whereas constitutive vWF secretion appeared to be altered in cases with minor histological signs of rejection. In pigs with von Willebrand disease that were transplanted with normal lungs without sign of rejection, plasma vWF was significantly increased in an amount expected from the estimated production of a normal lung. In the transplanted normal lung, there was no vWF overexpression by the ECs and no recruitment of ECs that initially did not express vWF. In SLA-incompatible transplantation, ECs were morphologically normal with increased and blurred vWF labeling, whereas plasma vWF levels remained normal, reflecting that EC activation is associated with an increased vWF production with probable diversion to storage pathway. This model depicts the changes of EC regulation of vWF secretion in pig lung transplants. However, this model cannot be directly extrapolated to human organ transplantation because animals did not receive any immunosuppressive therapy, which may be toxic to ECs.

Key Words: endothelial cells • lung transplantation • von Willebrand factor • immunohistochemistry • pigs

This article has been cited by other articles:

				H. Choi, K. Aboulfatova, H. J. Pownall, R. Cook, and J.-f. Dong Shear-induced Disulfide Bond Formation Regulates Adhesion Activity of von Willebrand Factor J. Biol. Chem., December 7, 2007; 282(49): 35604 - 35611. [Abstract] [Full Text] [PDF]

				D. S. Wilkes, T. M. Egan, and H. Y. Reynolds Lung Transplantation: Opportunities for Research and Clinical Advancement Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955. [Abstract] [Full Text] [PDF]

				H. J. Kang, G. Lee, J. Y. Kim, S. H. Lee, H. C. Wi, P. G. Hwang, D. H. Chung, and Y. T. Kim Pre-treatment of donor with 1-deamino-8-D-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 149 - 156. [Abstract] [Full Text] [PDF]

				K. K. Ray, D. A. Morrow, C. M. Gibson, S. Murphy, E. M. Antman, E. Braunwald, and for the ENTIRE-TIMI 23 Study Group Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy Eur. Heart J., March 1, 2005; 26(5): 440 - 446. [Abstract] [Full Text] [PDF]